Citation Impact
Citing Papers
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Rodent-borne diseases and their risks for public health
2009 Standout
The prevalence of serum antibodies to Toxoplasma gondii in Ontario mammals.
1978
Indications for control mechanisms in purine and pyrimidine biosynthesis as revealed by studies with inhibitors
1974 StandoutNobel
Toxoplasmosis
2004 Standout
Toxoplasma gondii infection in humans and animals in the United States
2008 Standout
Toxoplasma gondii: transmission, diagnosis and prevention
2002 Standout
Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
2009 Standout
cDNA cloning and expression of UDP-N-acetyl-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase T1 from Toxoplasma gondii
2003 StandoutNobel
Incidence ofToxoplasma gondiiin populations of domestic birds in the Czech republic
1993
Toxoplasmosis: A history of clinical observations
2009 Standout
Toxoplasma gondii Comprises Three Clonal Lineages: Correlation of Parasite Genotype with Human Disease
1995 Standout
Toxoplasma gondiiInfections in Chickens (Gallus domesticus): Prevalence, Clinical Disease, Diagnosis and Public Health Significance
2009
Pyrimethamine for Primary Prophylaxis of Toxoplasmic Encephalitis in Patients with Human Immunodeficiency Virus Infection: A Double-Blind, Randomized Trial
1996
The Prevalence and Source of Toxoplasma Infection in the Environment
1989
Toxoplasma gondii: from animals to humans
2000 Standout
Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
1990
Toxoplasmic Encephalitis in AIDS
1992 Standout
A plastid organelle as a drug target in apicomplexan parasites
1997 StandoutNature
Current Recommendations and Future Prospects in the Treatment of Toxoplasmosis
1989
Current Practices in the Management of Ocular Toxoplasmosis
1991
In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin againstToxoplasma gondii
1991
Effect of acyclovir combined with other antiherpetic agents on varicella zoster virus in vitro
1982 StandoutNobel
Comparative study of tissue culture and mouse inoculation methods for demonstration of Toxoplasma gondii
1987
Specific tlc Determination of Trimethoprim and Sulfamethoxazole in Plasma
1974 StandoutNobel
Impact of Spiramycin Treatment and Gestational Age on Maturation ofToxoplasma gondiiImmunoglobulin G Avidity in Pregnant Women
2007
Disminución en la prevalencia de anticuerpos contra Toxoplasma gondii en adultos del valle central de Costa Rica
2005
PREVALENCE OF ANTIBODIES TO Toxoplasma gondii IN WILD AND DOMESTIC ANIMALS OF NEW MEXICO, ARIZONA AND COLORADO
1976
FOLATE ANTAGONISTS AS ANTIBACTERIAL and ANTIPROTOZOAL AGENTS
1971 StandoutNobel
Potent Effect of Trimetrexate, a Lipid-Soluble Antifolate, on Toxoplasma gondii
1987
Structure-activity relationships among purines related to 6-mercaptopurine.
1958 StandoutNobel
Effect of Pyrimethamine on Folic Acid Metabolism in Streptococcus faecalis and Escherichia coli
1959 StandoutNobel
Mechanism of Action of Trimethoprim-Sulfamethoxazole--I
1973 StandoutNobel
EFFECTS OF PURINE ANTAGONISTS ON A DIAMINOPURINE-RESISTANT STRAIN OF LACTOBACILLUS CASEI
1953 StandoutNobel
Wild boars as sources for infectious diseases in livestock and humans
2009 Standout
Uracil antagonism and inhibition of mammary adenocarcinoma 755.
1958 StandoutNobel
ANTAGONISTS OF NUCLEIC ACID DERIVATIVES
1954 StandoutNobel
THE CHEMISTRY AND BIOCHEMISTRY OF PURINE ANALOGS
1954 StandoutNobel
PROPAGATION, MORPHOLOGY, AND BIOLOGY OF TOXOPLASMA
1956
Acquired Toxoplasmosis
1957
The Resistance of the Encysted Form of Toxoplasma gondii
1960
Toxoplasmic Encephalitis in Patients with AIDS
1988
PHARMACOLOGY AND TOXICOLOGY
1951
A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment
2010 Standout
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
1990
DIVISION OF BIOCHEMISTRY: A BIOCHEMICAL APPROACH TO CHEMOTHERAPY*
1961 StandoutNobel
Ocular Toxoplasmosis
1958
TRIMETHOPRIM, A SULPHONAMIDE POTENTIATOR
1968 StandoutNobel
Toxoplasmosis in the Adult
1960
Interferon-γ: the Major Mediator of Resistance Against Toxoplasma gondii
1988 StandoutScience
Effects of growth-inhibitors on amphibian tail blastema.
1959 StandoutNobel
Purine and Pyrimidine Antagonists
1955 StandoutNobel
Paper: Daraprim as an antagonist of folic and folinic acids
1952 StandoutNobel
THE PURINE METABOLISM OF A 6-MERCAPTOPURINE-RESISTANT LACTOBACILLUS CASEI
1953 StandoutNobel
Resistance to Inhibitors of Dihydrofolate Reductase in Strains of Lactobacillus Casei and Proteus Vulgaris
1966 StandoutNobel
TOXOPLASMA GONDII INFECTION IN RURAL GUATEMALAN CHILDREN
2005
A review of toxoplasmosis in cattle
1986
A review of toxoplasmosis in pigs
1986
Structures ofToxoplasma gondiiTachyzoites, Bradyzoites, and Sporozoites and Biology and Development of Tissue Cysts
1998 Standout
Trovafloxacin is active against Toxoplasma gondii
1996
ANTAGONISTS OF NUCLEIC ACID DERIVATIVES
1952 StandoutNobel
A Study of the Uptake and Degradation of Folic Acid, Citrovorum Factor, Aminopterin, and Pyrimethamine by Bacteria
1959 StandoutNobel
Minocycline in the chemotherapy of murine toxoplasmosis
1982
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Studies on 2,6‐diaminopurine and related substances in cultures of embryonic and sarcomatous rodent tissues
1951 StandoutNobel
Inhibition of Folate Biosynthesis and Function as a Basis for Chemotherapy
1965 StandoutNobel
The Continuing Challenges of Leprosy
2006 Standout
Potentiation of pyrimethamine by sulphadiazine in human malaria
1959
MICROBIOLOGICAL EFFECTS OF 6‐MERCAPTOPURINE
1954 StandoutNobel
Dihydrofolate reductases as targets for inhibitors
1980 StandoutNobel
Works of Nell Coleman being referenced
The Prevalence of Toxoplasma Antibodies in Guatemala and Costa Rica
1958
Relationship of Size of Inoculum to Time to Death in Mice Infected with Toxoplasma gondii
1956
A Comparison of Methods for the Isolation of Toxoplasma from Suspected Hosts
1958
Synergistic effect of sulfadiazine and daraprim against experimental toxoplasmosis in the mouse.
1953
Preservation of Toxoplasma gondii by Freezing
1956
Notes on the treatment of acute experimental toxoplasmosis of the mouse with chlortetracycline and tetracycline.
1954
The effect of sulfadimetine, sulfisoxazole, and sulfapyrazine against mouse toxoplasmosis.
1955
The Prevalence of Toxoplasmosis in Wild and Domesticated Animals of the Memphis Region
1959
An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis.
1955
An evaluation of the effect of sulfones on experimental toxoplasmosis in the mouse.
1957
Experimental Endamoeba Histolytica Infections in Rabbits with Reference to Chemotherapy
1952
Serological Response of a Rural Negro Population to the Sabin-Feldman Cytoplasm-Modifying Test for Toxoplasmosis
1956
The Relative Activity of the Common Sulfonamides against Experimental Toxoplasmosis in the Mouse
1953
Tests of 2,4-Diaminopyrimidines on Toxoplasmosis
1952